Skip to main content
. 2018 Apr 3;9(25):17576–17588. doi: 10.18632/oncotarget.24799

Figure 3. MIR212 and MIR222 expression levels and Kaplan-Meyer estimation of overall or disease-free survival, regarding miRNAs expression levels.

Figure 3

(A) Absolute expression levels of MIR221 in KNGL and KIT positive GIST cases (positive control). (B) Overall survival and (C) Disease free survival considering MIR221 gene expression. (D) Absolute expression levels of MIR222 in KNGL and KIT positive GIST cases. (E) Overall survival and (F) Disease-free survival concerning MIR222 gene expression. Error bar represents standard error. *p ≤ 0.05, **p ≤ 0.005 and ***p ≤ 0.0005.